手機掃碼訪問本站
微信咨詢
猜你喜歡
- 5470-70-2 / 6-甲基煙酸甲酯的制備方法和應(yīng)用報道
- 2,3-二苯基-5-氨基氯化四(氮)唑
- 磷酸三異丁酯
- 3,4-O-Isopropylidene ClindaMycin 2-[Bis(2,2,2-trichloroethyl)phosphate]
- 4-溴-1-甲基-1H-咪唑-5-甲醛
- (S)-(1R,3s,5S)-8-Methyl-8-azabicyclo[3.2.1]oct-6-en-3-yl 3-hydroxy-2-phenylpropanoate
- 1,2-二碘-4,5-二-N-辛氧基苯
- 2-(DIFLUOROMETHYL)ISONICOTINALDEHYDE
- C-ISOQUINOLIN-5-YL-METHYLAMINE
- 2687-94-7 / N-辛基吡咯烷酮的應(yīng)用
- 7727-54-0 / 過硫酸銨引發(fā)劑知多少？
- 2-苯并噻唑甲胺
- 96829-58-2/奧利司他為強效的特異性胃腸道脂肪酶抑制劑
- 五氯聯(lián)苯
- 9-JULOLIDINE BORONIC ACID
- 1,2-二(2-三氟甲基苯基)乙烷
- 3-(3-Bromopropyl)pyridine Hydrobromide
- 5-Phenyl-4-(1H-1,2,4-triazol-1-yl)cyclohexa-1,3-dione
- 5-溴-2-氟-3-甲氧基吡啶
- 十九烷二酸
- 2-苯基-2-丙醇
- Fmoc-L-beta-高苯丙氨酸
- 甲基4-氨基-3-氯化苯甲酸鹽
- (3Α,5Β,20S)-17,20-DIHYDROXYPREGNAN-3-YL Β-D-GLUCOPYRANOSIDURONIC ACID
- D-LUCIFERIN-6-O-BETA-D-GALACTOPYRANOSIDE
